PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis |
| Symptom | |hepatocellular carcinoma |
| Sentences | 261 |
| PubMedID- 25544880 | Evaluation of hepatocellular carcinoma development in patients with chronic hepatitis c by eob-mri. |
| PubMedID- 25667487 | Patients and methods: serum samples were collected preoperatively from 125 patients with hepatocellular carcinoma associated with hepatitis c virus infection who underwent curative hepatectomy. |
| PubMedID- 23125843 | The combined kir3ds1/hla-bw4-i80 genotype was also associated with decreased susceptibility for the development of hepatocellular carcinoma in patients with chronic hepatitis c virus (hcv; lopez-vazquez et al., 2005). |
| PubMedID- 22414050 | Aim: the role of interferon (ifn) therapy on prevention of hepatocellular carcinoma (hcc) in patients with hepatitis c virus (hcv)-related cirrhosis remains controversial. |
| PubMedID- 23306849 | The frequency of hepatocellular carcinoma in patients with autoimmune hepatitis and cirrhosis is 1-9 %, and annual occurrence in patients with cirrhosis is 1.1-1.9 %. |
| PubMedID- 25650331 | Purpose: to evaluate whether a hepatic fibrosis index (hfi), quantified on the basis of hepatic contour abnormality, is a risk factor for the development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c. |
| PubMedID- 20384529 | Objective: the aim of this nationwide cohort study was to assess the risk for hepatocellular carcinoma (hcc) in patients with chronic hepatitis b virus (hbv) infection or hbv and hepatitis c virus (hcv) co-infection in sweden, a low endemic country. |
| PubMedID- 23065464 | Data on the safety and efficacy of combination therapy in chronic hepatitis c patients with hepatocellular carcinoma (hcc) is scarce and even more so in hiv/hcv co-infected subjects. |
| PubMedID- 20305313 | Main indications for orthotopic liver transplantation were cholestatic liver disease (31%), viral-induced cirrhosis (25%), alcoholic liver disease (19%), hepatocellular carcinoma associated with hepatitis virus infection (13%), autoimmune cirrhosis (6%), cryptogenic acute liver failure (6%). |
| PubMedID- 25521761 | Here, we profiled the mutations and gene expressions of early and advanced hepatocellular carcinoma (hcc) related with hepatitis b-viral infection. |
| PubMedID- 26133818 | Correlation between polymorphisms in the human leukocyte antigen-dqb1 alleles and hepatitis b with primary hepatocellular carcinoma. |
| PubMedID- 24693297 | Transient elastography has also been used to assess the degree of liver fibrosis and the risk of hepatocellular carcinoma development in patients with chronic hepatitis (56, 57). |
| PubMedID- 24918150 | Antiviral therapy is not enough to prevent hepatocellular carcinoma development in patients with chronic hepatitis b. |
| PubMedID- 25173229 | Methods: levels of p3 and hbx mrna and status of p3 methylation were analyzed in human hepatocellular carcinoma (hcc) samples, with and without hepatitis b virus (hbv) infection, using quantitative reverse transcription-pcr and bisulfite sequencing. |
| PubMedID- 22966320 | Development of hepatocellular carcinoma in patients with chronic hepatitis c more than 10 years after sustained virological response to interferon therapy. |
| PubMedID- 25299117 | Matrix metalloproteinase-9 gene polymorphism in hepatocellular carcinoma patients with hepatitis b and c viruses. |
| PubMedID- 24440974 | Selection of reference genes for rt-qpcr analysis in tumor tissues from male hepatocellular carcinoma patients with hepatitis b infection and cirrhosis. |
| PubMedID- 24460352 | Prevalence of aflatoxin induced p53 mutation at codon 249 (r249s) in hepatocellular carcinoma patients with and without hepatitis b surface antigen (hbsag). |
| PubMedID- 25743000 | Objective: to determine the impact of phlebotomy on the laboratory values and the incidence of hepatocellular carcinoma (hcc) in patients with hepatitis c. |
| PubMedID- 20404016 | The incidence of hepatocellular carcinoma is rising due to alcohol drinking, hepatitis c viral infection and metabolic syndrome. |
| PubMedID- 23844083 | Protein kinase r modulates c-fos and c-jun signaling to promote proliferation of hepatocellular carcinoma with hepatitis c virus infection. |
| PubMedID- 21286221 | A 72-year-old japanese man underwent partial resection of the liver for hepatocellular carcinoma associated with hepatitis c viral infection. |
| PubMedID- 23463401 | hepatocellular carcinoma in patients with chronic hepatitis c virus infection in the asia-pacific region. |
| PubMedID- 21480326 | Few studies have evaluated the risk of cancers other than hepatocellular carcinoma associated with hepatitis b virus (hbv) infection. |
| PubMedID- 25559682 | The aim of the present study was to evaluate wfa(+) -m2bp as a predictor of hepatocellular carcinoma (hcc) development in patients with chronic hepatitis c. |
| PubMedID- 20207771 | Results: alpha-fetoprotein (afp) may be used in conjunction with abdominal ultrasound for early detection of hepatocellular carcinoma (hcc) in patients with chronic hepatitis or cirrhosis associated with hepatitis b or c virus infection. |
| PubMedID- 23213040 | Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis b virus infection. |
| PubMedID- 21331763 | Post-challenge hyperglycemia is a significant risk factor for the development of hepatocellular carcinoma in patients with chronic hepatitis c. |
| PubMedID- 26064099 | Three patients (27%) had other extracolonic cancers or hematologic malignancies: one with hepatocellular carcinoma (hcc) associated with chronic hepatitis b, one with lung cancer, and one with myelodysplastic syndrome (mds). |
| PubMedID- 24123097 | On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis b receiving entecavir. |
| PubMedID- 21234423 | A 73-year-old female with history of hepatocellular carcinoma due to long-standing hepatitis c, presented to the emergency center with a sudden syncopal episode at home. |
| PubMedID- 24745029 | We evaluated clinicopathological factors affecting survival and recurrence after initial hepatectomy in non-b non-c (nbnc) hepatocellular carcinoma (hcc) patients with comparison to hepatitis b or c virus, paying attention to relationship between alcohol consumption and histopathological findings. |
| PubMedID- 21103209 | Three years earlier, the patient had undergone transcatheter arterial embolization and radiofrequency treatment based on a diagnosis of hepatocellular carcinoma due to hepatitis b by another doctor. |
| PubMedID- 20401917 | Favorable long-term surgical outcomes of hepatocellular carcinoma in patients with hepatitis b envelope antibody. |
| PubMedID- 25616940 | Time interval to recurrence as a predictor of overall survival in salvage liver transplantation for patients with hepatocellular carcinoma associated with hepatitis b virus. |
| PubMedID- 24367218 | Critical reappraisal of risk factors for occurrence of hepatocellular carcinoma in patients with hepatitis c virus. |
| PubMedID- 24995497 | Aspartate aminotransferase to platelet ratio index as a prospective predictor of hepatocellular carcinoma risk in patients with chronic hepatitis b virus infection. |
| PubMedID- 23098451 | Why is hepatocellular carcinoma less attributable to viral hepatitis in yemen. |
| PubMedID- 22654459 | He was diagnosed with hepatocellular carcinoma (hcc) arising from decompensated hepatitis b virus (hbv)-related cirrhosis. |
| PubMedID- 21677494 | We report a case of an 80-year-old male who suffered from intractable hepatic encephalopathy and hepatocellular carcinoma( hcc), associated with hepatitis type c-related liver cirrhosis. |
| PubMedID- 23404391 | Repeat hepatectomies for hepatic malignant lymphoma and hepatocellular carcinoma associated with chronic hepatitis c: report of a case. |
| PubMedID- 25569223 | Blood gene signature for early hepatocellular carcinoma detection in patients with chronic hepatitis b. |
| PubMedID- 23225825 | The present study was approved by our ethics committee and written informed consent was obtained from all 48 male patients scheduled for liver transplantation for cirrhosis or hepatocellular carcinoma with chronic hepatitis b virus infection. |
| PubMedID- 23853347 | Liver cirrhosis and/or hepatocellular carcinoma develops in 15-40% of chronic hepatitis b virus infected patients without treatment. |
| PubMedID- 25788045 | Methods: serum ferritin was measured in 487 chronic hepatitis c patients without history of hepatocellular carcinoma (hcc) after excluding patients in phlebotomy, those with overt chronic gastrointestinal bleeding and those who achieved sustained virological response before enrollment. |
| PubMedID- 24179611 | Chemoprevention of hepatocellular carcinoma in patients with hepatitis c virus related cirrhosis. |
| PubMedID- 21175807 | hepatocellular carcinoma with persistent hepatitis b virus infection shows unusual downregulation of ras expression and differential response to ras mediated signaling. |
| PubMedID- 23090836 | Role of leptin receptor (lepr) gene polymorphisms and haplotypes in susceptibility to hepatocellular carcinoma in subjects with chronic hepatitis b virus infection. |
| PubMedID- 21129375 | Background & aims: interferon reportedly decreases the incidence of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c. |
| PubMedID- 21718500 | Reported a correlation between a diabetic pattern of the 75 g oral glucose tolerance test ogtt and hepatocarcinogenesis and considered it a significant risk factor for hepatocellular carcinoma (hcc) in patients with hepatitis c virus . |